In February of 2005 an FDA advisory panel recommended the FDA allow Bextra and Celebrex to remain on the market, though most experts agreed the drugs presented potentially fatal heart attack and stroke risks. However, the FDA elected to pull Bextra from the market. This was a break from usual practice, as the FDA usually goes along with advisory panel recommendations.
Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.